Knowledge, attitudes, and practices regarding antimalarial chemoprophylaxis in U.S. Peace Corps Volunteers--Africa, 2013
- PMID: 24918487
- PMCID: PMC5779364
Knowledge, attitudes, and practices regarding antimalarial chemoprophylaxis in U.S. Peace Corps Volunteers--Africa, 2013
Abstract
Long-term travelers to areas where malaria is endemic are at risk for this potentially fatal disease; however, malaria can be prevented through the use of insecticide-treated bednets, mosquito repellents, and chemoprophylaxis. Three options for chemoprophylaxis are available in the Africa region: mefloquine, doxycycline, and atovaquone-proguanil. These options differ by dosing regimen, cost, and side effect profile. Long-term adverse effects of these drugs have been reported rarely.
References
-
- Chen LH, Wilson ME, Schlagenhauf P. Prevention of malaria in long-term travelers. JAMA. 2006;296:2234–44. - PubMed
-
- Peace Corps Office of Health Services. Technical guideline 840: prevention of malaria. Washington, DC: Peace Corps Office of Health Services; 2013.
-
- Peace Corps Office of Health Services. Health of the volunteer [multiple editions] Washington, DC: Peace Corps Office of Health Services; 2009–2012.
-
- Lobel HO, Varma JK, Miani M, et al. Monitoring for mefloquine-resistant Plasmodium falciparum in Africa: implications for travelers’ health. Am J Trop Med Hyg. 1998;59:129–32. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical